Literature DB >> 17964914

Obesity and the polycystic ovary syndrome.

Michael Magnotti1, Walter Futterweit.   

Abstract

Polycystic ovarian syndrome (PCOS) is extremely common among reproductive-aged women, but often goes undiagnosed. PCOS is associated with the metabolic syndrome and carries a greatly increased risk of impaired glucose tolerance and type 2 diabetes mellitus, and cardiovascular risks. Treatment of PCOS may provide relief of cosmetic problems and depression by improving patient self-esteem. In addition, because of its association with the metabolic syndrome, type 2 diabetes mellitus, and cardiovascular disease, its recognition and treatment can potentially be life saving. This article reviews the impact, pathophysiology, and associated risks of obesity and the metabolic syndrome in PCOS.

Entities:  

Mesh:

Year:  2007        PMID: 17964914     DOI: 10.1016/j.mcna.2007.06.010

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  6 in total

1.  A case of successful treatment of comorbid obesity and polycystic ovarian disease with add-on metformin in bipolar disorder.

Authors:  Sri M Agarwal; Rishikesh V Behere; Ganesan Venkatasubramanian; Naren P Rao; Shivarama Varambally; B N Gangadhar
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Correlates of the metabolic syndrome among a sample of women in the San Juan Metropolitan area of Puerto Rico.

Authors:  Ana Patricia Ortiz; Erick Suárez; Giovanna Beauchamp; Josefina Romaguera; Marievelisse Soto-Salgado; Cynthia M Pérez
Journal:  Metab Syndr Relat Disord       Date:  2010-06       Impact factor: 1.894

3.  Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United States.

Authors:  Hind A Beydoun; May A Beydoun; Natasha Wiggins; Laurel Stadtmauer
Journal:  Maturitas       Date:  2011-11-15       Impact factor: 4.342

4.  Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome.

Authors:  Melissa J Romero-Aleshire; Maggie K Diamond-Stanic; Alyssa H Hasty; Patricia B Hoyer; Heddwen L Brooks
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-13       Impact factor: 3.619

5.  Anti-Müllerian hormone was independently associated with central obesity but not with general obesity in women with PCOS.

Authors:  Xiying Zeng; Yinxiang Huang; Mulin Zhang; Yun Chen; Jiawen Ye; Yan Han; Danyan Ma; Xin Zheng; Xiaohong Yan; Changqin Liu
Journal:  Endocr Connect       Date:  2022-01-10       Impact factor: 3.335

6.  Anthropometric and Biochemical Characteristics of Polycystic Ovarian Syndrome in South Indian Women Using AES-2006 Criteria.

Authors:  Sujatha Thathapudi; Vijayalakshmi Kodati; Jayashankar Erukkambattu; Anuradha Katragadda; Uma Addepally; Qurratulain Hasan
Journal:  Int J Endocrinol Metab       Date:  2014-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.